.
"future placement of tooth implants if needed will be much easier," he said..
cambridge's bluebird bio licenses delivery tech to novartis, gsk.
the total amount paid out in life claims was £129.4m, with £13.46m paid in terminal illness claims.. at this, shehbaz reassured them that the interview was taken out of context. this is unedited, unformatted feed from the press trust of india wire..
meet other global citizens who care about the same issues you do. keep updated on what they're doing to change the world..
.